Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer, Margaret C. Dunagin, Stefan Torborg, Eduardo A. Torre, Benjamin Emert, Clemens Krepler, Marilda Beqiri, Katrin Sproesser, Patricia Brafford, Min Xiao, Elliott Eggan, Ioannis N. Anastopoulos, Cesar A. Vargas-García, Abhyudai Singh, Katherine L. Nathanson, Meenhard Herlyn, Arjun Raj
Topics & Concepts
ReprogrammingEpigeneticsTranscription factorBiologyDrug resistanceCancer cellCellGeneCell biologyCancer researchGeneticsCancerCancer Genomics and DiagnosticsCancer Cells and MetastasisCRISPR and Genetic Engineering